Valuation of Long Term Care (Ltc) Health Insurance Contract Using Multistate Model

In this paper, we are using multistate model to evaluate Long Term Care (LTC) health insurance contract. Some products in LTC contract such as stand alone Annuity, LTC as a rider benefit, Enhanced pension and Insurance package are discussed. We use Discrete Time Markov Chains (DTMC) to model health status of each of the patients. Every time, a patient is exposed to one of the status that already set in the status space, for example: health, ill and death. We also consider evaluating premiums and reserves generated by this model which also useful for the practioneers and insurance companies

Does long-term care subsidisation reduce hospital admissions?

One of the intended effects of an integrated network of long-term care (LTC) services lies in the reduction of (unnecessary) health care utilisation. This paper draws upon the quasi-experimental evidence from Spain to examine the causal effect of the expansion of affordable long-term care (LTC) access (after the introduction of a new universal LTC subsidy) on hospital admissions (both on the internal and external margin) and its duration or length of stay (LOS). We find robust evidence of a reduction in both measures of hospitalisation among both those receiving a caregiving allowance and, though less intense, among beneficiaries of publicly funded home care (amounting to 11% of total hospital costs), and among regions coordinating health and social care. Consistently, a reduction in the subsidy is found to significantly attenuate such effects

Virtual Reality and Well-Being in Older Adults: Results from a Pilot Implementation of Virtual Reality in Long-Term Care

This paper describes the findings of a pilot implementation project that explored the potential of virtual reality (VR) technology in recreational programming to support the well-being of older adults in long-term care (LTC) homes

Integrating Residents as Partners in Long-Term Care (LTC) Research

This research poster summarizes patient-engagement throughout the study COVID-19: Implementation of virtual P.I.E.C.E.S for LTC resident care planning with family to build and sustain team collaboration and workforce resilience . It describes two implementation frameworks (CFIR and PRISM) as well as two patient-engagement tools (PEIRS and PPEET) in relation to the study. Lastly, it offers preliminary insights into the current landscape of patient-engagement in research

Provision of Long Term Care for the Elderly in Poland in Comparison to Other European Countries

In recent years, population ageing has attracted the attention of research and policy advisors in all European countries. Several policy actions have been directed toward ensuring optimal long-term care (LTC) for elderly people while maintaining fiscal rationality. LTC systems are very different across all European countries. Their design is characterized by diverse arrangements for the provision of care/organization and financing. Despite general concerns, the Polish LTC system is still at the bottom of the pile in terms of the organization and provision of care

Assessing Needs of Care in European Nations. ENEPRI Policy Brief No. 14, 28 December 2012

This Policy Brief presents the research questions, main results and policy implications and recommendations of the seven Work Packages that formed the basis of the ANCIEN research project, financed under the 7th EU Research Framework Programme of the European Commission. Carried out over a 44-month period and involving 20 partners from EU member states, the project principally concerns the future of long-term care (LTC) for the elderly in Europe and addresses two questions in particular: How will need, demand, supply and use of LTC develop? How do different systems of LTC perform

FAQs about medical consent & Pfizer-BioNTech booster doses for long-term care residents : a resource for providers participating in the CDC COVID-19 vaccination program, long-term care residents & their families

In response to inquiries about medical consent surrounding the administration of a booster shot of Pfizer-BioNTech COVID-19 vaccine to residents in long-term care (LTC) settings at least six months after their Pfizer-BioNTech primary series , the Centers for Disease Control and Prevention (CDC) has developed the following responses to frequently asked questions (FAQs).These FAQs are intended to clarify that medical consent is not required by federal law for COVID-19 vaccination in the United States.In response to inquiries about medical consent surrounding the administration of a booster shot of Pfizer-BioNTech COVID-19 vaccine to residents in long-term care (LTC) settings at least six months after their Pfizer-BioNTech primary series1\ua0, the Centers for Disease Control and Prevention (CDC) has developed the following responses to frequently asked questions (FAQs).20211033

Trends and issues in the Medicaid 1915(c) waiver program.

Over the past 15 years, Medicaid 1915(c) home and community-based waivers have made a substantial contribution to States' efforts to transform their long-term care (LTC) systems from largely institutional to community-based systems. By 1997, every State had implemented a waiver program for at least some subgroups of individuals with disabilities, and expenditures increased from $3.8 million in 1982 to more than$8.1 billion in 1997. Emerging, as well as long-standing, policy issues related to the waiver program include concerns with access, variation in availability by disability group, State decisions related to the provision of community-based LTC, and evidence on effectiveness

Social/health maintenance organization and fee-for-service health outcomes over time.

Evaluating the performance of long-term care (LTC) demonstrations requires longitudinal assessment of multiple outcomes where selective mortality and disenrollment, if not accounted for, can give the appearance of reduced (or enhanced) efficacy. We assessed outcomes in social/health maintenance organizations (S/HMOs) and Medicare fee-for-service (FFS) care using a multivariate model to estimate active life expectancy (ALE). S/HMO enrollees and samples of FFS clients in four sites were analyzed and outcome differences assessed for a 3-year period. Results provide insights into S/HMO performance under different conditions and, more generally, into evaluating LTC demonstrations without randomized client and control groups

Investigating the market potential for customised long term care insurance products

Previous economic research into long-term care (LTC) has mainly been focussed on one issue: the reasons why the LTC insurance market has not been successful. In this contribution, we analyse the prospects for a new type of insurance policy, which offers a top-up on the resources already available to the individual. We abstract from most problems inherent in LTC insurance markets and derive premium rates for various types of insurance policies. Generally, we find that the top-up option reduces premium rates considerably, to the point where it might be expected that a substantial number of people would take up policies, were they available